Literature DB >> 30086461

Integration of 3D printing with dosage forms: A new perspective for modern healthcare.

Shende Pravin1, Agrawal Sudhir2.   

Abstract

3D printing is an additive manufacturing technique capable of producing various 3D drug products, medical devices, tissues and organs from digital designs. The first FDA approved 3D drug product, Spritam®, has encouraged and attracted many researchers in this field with research undergoing to develop various customized dosage forms. This review aims to introduce 3D printing, its history, advantages, challenges and various techniques used in fabrication of drug products. This review also assesses the advantages and importance of customized dosage forms obtained from 3D printing. It focuses on the applications of 3D printing in various conditions such as cancer, diabetes, cardiovascular disorders, neurodegenerative disease and other diseases employing anatomical models, tissues and organs fabrication and importance of individualized dose. Various regulatory issues, challenges and possible disruptions that 3D printing show impact on healthcare and manufacturing are discussed. Overall, this review on 3D printing technology has described the advancements in manufacturing and the futuristic potential for therapeutic approaches to bring in a vast array of useful applications and benefits to human.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  3D; Applications in healthcare; Dosage forms; Regulatory issues

Mesh:

Substances:

Year:  2018        PMID: 30086461     DOI: 10.1016/j.biopha.2018.07.167

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  11 in total

Review 1.  3D Printed Personalized Medicine for Cancer: Applications for Betterment of Diagnosis, Prognosis and Treatment.

Authors:  Harshada Bhuskute; Pravin Shende; Bala Prabhakar
Journal:  AAPS PharmSciTech       Date:  2021-12-01       Impact factor: 3.246

2.  A Design Approach to Optimise Secure Remote Three-Dimensional (3D) Printing: A Proof-of-Concept Study towards Advancement in Telemedicine.

Authors:  Xiao Wen Kok; Anisha Singh; Bahijja Tolulope Raimi-Abraham
Journal:  Healthcare (Basel)       Date:  2022-06-15

Review 3.  An updated review on application of 3D printing in fabricating pharmaceutical dosage forms.

Authors:  Rabinarayan Parhi; Goutam Kumar Jena
Journal:  Drug Deliv Transl Res       Date:  2021-10-06       Impact factor: 5.671

4.  Introducing Fiber-Assisted Colorimetric Measurements as a Quality Control Tool of Hot Melt Extruded Filaments.

Authors:  Rebecca Chamberlain; Eirini Mangiorou; Björn Fischer
Journal:  Pharmaceutics       Date:  2022-05-14       Impact factor: 6.525

5.  3D printing for airway disease.

Authors:  Abdul Hamid Alraiyes; Sameer K Avasarala; Michael S Machuzak; Thomas R Gildea
Journal:  AME Med J       Date:  2019-02-13

Review 6.  Trends in 3D Printing Processes for Biomedical Field: Opportunities and Challenges.

Authors:  Alina Ghilan; Aurica P Chiriac; Loredana E Nita; Alina G Rusu; Iordana Neamtu; Vlad Mihai Chiriac
Journal:  J Polym Environ       Date:  2020-03-31       Impact factor: 3.667

Review 7.  Practicality of 3D Printed Personalized Medicines in Therapeutics.

Authors:  Hilda Amekyeh; Faris Tarlochan; Nashiru Billa
Journal:  Front Pharmacol       Date:  2021-04-12       Impact factor: 5.810

Review 8.  The Development of Innovative Dosage Forms of the Fixed-Dose Combination of Active Pharmaceutical Ingredients.

Authors:  Magdalena Janczura; Szymon Sip; Judyta Cielecka-Piontek
Journal:  Pharmaceutics       Date:  2022-04-11       Impact factor: 6.525

9.  Production of Reproducible Filament Batches for the Fabrication of 3D Printed Oral Forms.

Authors:  Stéphane Roulon; Ian Soulairol; Valérie Lavastre; Nicolas Payre; Maxime Cazes; Laurent Delbreilh; Jean Alié
Journal:  Pharmaceutics       Date:  2021-03-31       Impact factor: 6.321

Review 10.  Polysaccharide 3D Printing for Drug Delivery Applications.

Authors:  Alexandra Zamboulis; Georgia Michailidou; Ioanna Koumentakou; Dimitrios N Bikiaris
Journal:  Pharmaceutics       Date:  2022-01-07       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.